MYELODYSPLASTIC SYNDROME

This adverse event was reported 8901 times

These drugs are most commonly taken by patients reporting MYELODYSPLASTIC SYNDROME:

# Drug Count
0 LENALIDOMIDE 1678
1 CYCLOPHOSPHAMIDE 1241
2 RITUXIMAB 778
3 ETOPOSIDE 645
4 PREDNISONE 636
5 DEXAMETHASONE 602
6 METHOTREXATE SODIUM 588
7 DEXAMETHASONE 1.5 MG 569
8 METHOTREXATE 546
9 DOXORUBICIN 533
See all common drugs associated with MYELODYSPLASTIC SYNDROME

MYELODYSPLASTIC SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CARMUSTINE 200 0.0684
1 IBRITUMOMAB TIUXETAN 71 0.0582
2 MITOXANTRONE HYDROCHLORIDE 186 0.0527
3 AZACITIDINE 481 0.0482
4 CLADRIBINE 43 0.0442
5 STREPTOZOCIN 4 0.0370
6 BROSIMUM ACUTIFOLIUM BARK, HIMATANTHUS SUCUUBA BARK, MANSOA ALLIACEA BARK AND LEAF, MINQUARTIA GUIANENIS BARK, PHYLLANTHUS NIRURI WHOLE 2 0.0364
7 INDIUM IN -111 PENTETREOTIDE 3 0.0309
8 DECITABINE 63 0.0307
9 CARFILZOMIB 2 0.0303
See all drugs enriched for association with MYELODYSPLASTIC SYNDROME

MYELODYSPLASTIC SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Stimulant Laxative [EPC] 11 0.0012
1 Angiotensin Converting Enzyme Inhibitor [EPC] 88 0.0012
2 Anti-coagulant [EPC] 1 0.0011
3 Nonsteroidal Anti-inflammatory Drug [EPC] 540 0.0008
4 Tetracycline-class Drug [EPC] 19 0.0007
5 Prostaglandin Analog [EPC] 32 0.0007
6 Antiarrhythmic [EPC] 4 0.0005
7 Insulin Analog [EPC] 79 0.0004
See all drug classes enriched for association with MYELODYSPLASTIC SYNDROME